C

CrystalGenomics Inc
KOSDAQ:083790

Watchlist Manager
CrystalGenomics Inc
KOSDAQ:083790
Watchlist
Price: 1 476 KRW 0.41% Market Closed
Market Cap: 113.5B KRW

Wall Street
Price Targets

Price Targets Summary
CrystalGenomics Inc

There are no price targets for CrystalGenomics Inc.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
CrystalGenomics Inc Competitors:
Price Targets
1801
Innovent Biologics Inc
33% Upside
NBIX
Neurocrine Biosciences Inc
24% Upside
4593
Healios KK
131% Upside
ORGO
Organogenesis Holdings Inc
48% Upside
BCYC
Bicycle Therapeutics PLC
199% Upside
RCUS
Arcus Biosciences Inc
42% Upside
LTRN
Lantern Pharma Inc.
511% Upside
145020
Hugel Inc
57% Upside

Revenue
Forecast

Revenue Estimate
CrystalGenomics Inc

For the last 13 years the compound annual growth rate for CrystalGenomics Inc's revenue is 5%. The projected CAGR for the next 8 years is 46%.

5%
Past Growth
46%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
CrystalGenomics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
CrystalGenomics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CrystalGenomics Inc's stock price target?
Not Available

CrystalGenomics Inc doesn't have any price targets made by Wall Street professionals.

What is CrystalGenomics Inc's Revenue forecast?
Projected CAGR
46%

For the last 13 years the compound annual growth rate for CrystalGenomics Inc's revenue is 5%. The projected CAGR for the next 8 years is 46%.

Back to Top